Endovascular Management of Renal Angiomyolipomas: Do Coils Have a Benefit in Terms of Clinical Success Rates?

Overview

Journal Diagn Interv Radiol

Publisher Galenos Publishing House

Date 2022 Dec 23

PMID 36550760

Authors

Javid Ahmadov

Ferdi Cay

Gonca Eldem

Bulent Akdogan

Cenk Yucel Bilen

Fazil Tuncay Aki

Barbaros Erhan Cil

Ali Ergen

Bora Peynircioglu

Affiliations

Soon will be listed here.

Abstract

PURPOSE This study evaluated single center results of endovascular treatment in renal angiomyolipoma (AML) to determine whether there is clinical relevance of adding proximal coil embolization to distal particle embolization in terms of safety, efficacy and retreatment rates. METHODS A retrospective analysis was performed to evaluate patients undergoing transarterial embolization for renal AMLs from January 2007 to October 2020. Parameters regarding patient and tumor characteristics, embolization technique, treatment outcome and complications were recorded. Patients were divided into two groups as A (only particle group) and B (particle + coil group) based on the type of embolic agent used for treatment. Comparative analysis was performed between the two groups in terms of tumor size reduction, retreatment and complication rates. RESULT Forty-two patients (37 (88.1%) female, 5 (11.9%) male) harboring 48 AMLs were included in the study. The mean age was 43.46 (range 20 to 78). The technical success rate was 95.8% (46 of 48 procedures). The mean size reduction was 1.94±1 cm (p < 0.001) after treatments however, no significant difference was seen between groups in terms of tumor size reduction. Retreatment rates were 3.1% (1 of 32 cases) in group A and 14.3% (2 of 14 cases) in group B (p = 0.21). No significant difference was found between groups in terms of bleeding and complication rates during the perioperative period. Mean follow-up duration was 26.48±25.71 (range from 2 to 102) months. CONCLUSION In this study, no clear supplementary benefit was observed in terms of safety, and efficacy with the adjunction of coils to distal particle embolization in the management of AMLs.

References

Anis O, Rimon U, Ramon J, Khaitovich B, Zilberman D, Portnoy O . Selective Arterial Embolization for Large or Symptomatic Renal Angiomyolipoma: 10 Years of Follow-up. Urology. 2019; 135:82-87. DOI: 10.1016/j.urology.2019.09.035. View

Chan K, Chedgy E, Bent C, Turner K . Surveillance imaging for sporadic renal angiomyolipoma less than 40 mm: lessons learnt and recommendations from the experience of a large district general hospital. Ann R Coll Surg Engl. 2018; 100(6):480-484. PMC: 6111918. DOI: 10.1308/rcsann.2018.0040. View

Lenton J, Kessel D, Watkinson A . Embolization of renal angiomyolipoma: immediate complications and long-term outcomes. Clin Radiol. 2008; 63(8):864-70. DOI: 10.1016/j.crad.2008.02.005. View

Patatas K, Robinson G, Ettles D, Lakshminarayan R . Patterns of renal angiomyolipoma regression post embolisation on medium- to long-term follow-up. Br J Radiol. 2013; 86(1024):20120633. PMC: 3635789. DOI: 10.1259/bjr.20120633. View

Lee S, Park H, Hyun D, Cho S, Park K, Shin S . Radiologic and clinical results of transarterial ethanol embolization for renal angiomyolipoma. Eur Radiol. 2021; 31(9):6568-6577. DOI: 10.1007/s00330-021-07831-y. View

. Fatal nontarget embolization via an intrafibroid arterial venous fistula during uterine fibroid embolization. J Vasc Interv Radiol. 2009; 20(3):419-20. DOI: 10.1016/j.jvir.2008.12.412. View

Brown K . Fatal pulmonary complications after arterial embolization with 40-120- micro m tris-acryl gelatin microspheres. J Vasc Interv Radiol. 2004; 15(2 Pt 1):197-200. DOI: 10.1097/01.rvi.0000109400.52762.1f. View

Shin B, Do Y, Cho H, Kim D, Hahm T, Kim C . Effects of repeat bolus ethanol injections on cardiopulmonary hemodynamic changes during embolotherapy of arteriovenous malformations of the extremities. J Vasc Interv Radiol. 2010; 21(1):81-9. DOI: 10.1016/j.jvir.2009.09.026. View

Kothary N, Soulen M, Clark T, Wein A, Shlansky-Goldberg R, Crino P . Renal angiomyolipoma: long-term results after arterial embolization. J Vasc Interv Radiol. 2005; 16(1):45-50. DOI: 10.1097/01.RVI.0000143769.79774.70. View

10.

Ewalt D, Diamond N, Rees C, Sparagana S, Delgado M, Batchelor L . Long-term outcome of transcatheter embolization of renal angiomyolipomas due to tuberous sclerosis complex. J Urol. 2005; 174(5):1764-6. DOI: 10.1097/01.ju.0000177497.31986.64. View

11.

Eble J . Angiomyolipoma of kidney. Semin Diagn Pathol. 1998; 15(1):21-40. View

12.

Haugan G, Drageset J, Andre B, Kukulu K, Mugisha J, Utvaer B . Assessing quality of life in older adults: psychometric properties of the OPQoL-brief questionnaire in a nursing home population. Health Qual Life Outcomes. 2020; 18(1):1. PMC: 6941243. DOI: 10.1186/s12955-019-1245-3. View

13.

Urbano J, Paul L, Cabrera M, Alonso-Burgos A, Gomez D . Elective and Emergency Renal Angiomyolipoma Embolization with Ethylene Vinyl Alcohol Copolymer: Feasibility and Initial Experience. J Vasc Interv Radiol. 2017; 28(6):832-839. DOI: 10.1016/j.jvir.2017.01.017. View

14.

Hocquelet A, Cornelis F, Le Bras Y, Meyer M, Tricaud E, Lasserre A . Long-term results of preventive embolization of renal angiomyolipomas: evaluation of predictive factors of volume decrease. Eur Radiol. 2014; 24(8):1785-93. DOI: 10.1007/s00330-014-3244-4. View

15.

Rabenou R, Charles H . Differentiation of Sporadic Versus Tuberous Sclerosis Complex-Associated Angiomyolipoma. AJR Am J Roentgenol. 2015; 205(2):292-301. DOI: 10.2214/AJR.14.14255. View

16.

Oesterling J, Fishman E, Goldman S, Marshall F . The management of renal angiomyolipoma. J Urol. 1986; 135(6):1121-4. DOI: 10.1016/s0022-5347(17)46013-7. View

17.

Yamakado K, Tanaka N, Nakagawa T, Kobayashi S, Yanagawa M, Takeda K . Renal angiomyolipoma: relationships between tumor size, aneurysm formation, and rupture. Radiology. 2002; 225(1):78-82. DOI: 10.1148/radiol.2251011477. View

18.

Fernandez-Pello S, Hora M, Kuusk T, Tahbaz R, Dabestani S, Abu-Ghanem Y . Management of Sporadic Renal Angiomyolipomas: A Systematic Review of Available Evidence to Guide Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel. Eur Urol Oncol. 2019; 3(1):57-72. DOI: 10.1016/j.euo.2019.04.005. View

19.

Filippiadis D, Binkert C, Pellerin O, Hoffmann R, Krajina A, Pereira P . Cirse Quality Assurance Document and Standards for Classification of Complications: The Cirse Classification System. Cardiovasc Intervent Radiol. 2017; 40(8):1141-1146. DOI: 10.1007/s00270-017-1703-4. View

20.

Murray T, Doyle F, Lee M . Transarterial Embolization of Angiomyolipoma: A Systematic Review. J Urol. 2015; 194(3):635-9. DOI: 10.1016/j.juro.2015.04.081. View